Human Papilloma Virus Infection Clinical Trial
Official title:
The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar
The purpose of this study is to find out whether Self-HPV may be an accurate method for the follow-up of women with a history of HPV infection.
The efficacy and the availability of cold coagulation render it a valuable technique for the
treatment of precancerous lesions in low-resource settings. The Human Papillomavirus (HPV)
test performed by women themselves (HPV self-test) could be an efficient method to assess
the long-term risk of recurrent/persistent disease in women with a history of HPV infection
and cervical intra-epithelial lesions grade 2 or higher (CIN2+).
A total of 443 HPV-positive women, aged 30-65 years, have been selected through a screening
campaign conducted in Ambanja, Madagascar, between 2013 and 2015. Of these, 260 have been
treated by cold coagulation, conisation or electrocauterization. A follow-up visit at 1-3
years after primary screening will be organized for all HPV-positive women detected at
primary screening. Participants will perform an HPV self-test. A sample for cytology and HPV
testing will also be collected by the physician. The goal of the study will be the
histological search for CIN2+ lesions at one to three years after primary screening.
The investigators expect to see that Self-HPV may be an accurate method for the follow-up of
women with a history of HPV infection.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04199078 -
Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.
|
N/A | |
Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
Active, not recruiting |
NCT02258659 -
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
|
Phase 2 | |
Completed |
NCT02714114 -
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
|
N/A | |
Completed |
NCT00303823 -
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
|
Phase 2 | |
Not yet recruiting |
NCT05510830 -
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
|
N/A | |
Completed |
NCT04002154 -
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV
|
N/A | |
Not yet recruiting |
NCT06123533 -
Understanding Women's Values in Managing Human Papillomavirus (HPV)
|
||
Completed |
NCT04624568 -
Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance
|
N/A | |
Completed |
NCT05694728 -
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
|
Phase 2 | |
Completed |
NCT04391647 -
Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples
|
||
Recruiting |
NCT05439083 -
Immunogenicity of 9-valent HPV Vaccine
|
Phase 4 | |
Completed |
NCT01539668 -
Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas
|
Phase 0 | |
Completed |
NCT01446198 -
Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHERâ„¢ System
|
N/A | |
Recruiting |
NCT06467942 -
Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection
|
N/A | |
Completed |
NCT01567813 -
Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070)
|
||
Completed |
NCT02067507 -
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County
|
N/A | |
Recruiting |
NCT01387997 -
e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
|
N/A | |
Completed |
NCT02634190 -
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
|
||
Completed |
NCT00054041 -
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
|
Phase 2 |